{
    "title": "HYBERNATUS",
    "link": "https://www.thebottomline.org.uk/summaries/icm/hybernatus-2/",
    "summary": "In patients with convulsive status epilepticus, does the addition of therapeutic hypothermia to standard care improve neurological outcomes?",
    "full_content": "\nTweet\n\nHypothermia for Neuroprotection in Convulsive Status Epilepticus\nLegriel S\u00a0et al. N Engl J Med 2016;375:2457-67. DOI: 10.1056/NEJMoa1608193\n\u00a0\nClinical Question\n\nIn\u00a0patients with convulsive status epilepticus, does the addition of therapeutic hypothermia to standard care improve neurological outcomes?\n\nDesign\n\nRandomised controlled trial\n\nConsecutive recruitment\nComputer-generated permuted blocks\n\n\nMulti-centre\nOpen-labelled\nParallel arm\u00a0standard care\nPower calculation: 135\u00a0patients per group\u00a0to demonstrate 20% difference in Glasgow Outcome Score (GOS) of 5 at 90 days (90% power)\n\nAssumed 40% in standard care group vs 60% in intervention\u00a0group\nIntention to treat analysis\n\n\n\nSetting\n\n11 French ICUs\nData collected: March\u00a02011 \u2013 January 2015\n\nPopulation\n\nInclusion criteria:\n\n\u226518 years old\nConvulsive status epilepticus admitted to ICU defined\u00a0as 5 minutes or more of continuous clinical seizure activity or more than two seizures without a return to baseline in the interval\nAdmitted less than 8 hours after the onset of seizures\nReceiving mechanical ventilation\n\n\nExclusion criteria:\n\nFull recovery from seizure (defined as a return to the baseline state of consciousness)\nEmergency surgery that would preclude therapeutic hypothermia\nPostanoxic status epilepticus\nImminent death\nDo-not-resuscitate orders\nBacterial meningitis was added in January 2013\n\n\nParticipant numbers\n\n270\u00a0patients enrolled. 2 withdrew consent\n138 assigned to intervention group and 130 to control group\n\n\nBaseline characteristics:\n\nMedian age 57\n65% male\n49% known history of epilepsy\n\n\n\nIntervention\n\nTarget core temperature of 32 to 34\u00b0C as rapidly as possible post randomisation\nTarget temperature maintained for 24 hours\nHypothermia induced with ice-cold IV\u00a0fluids at 4\u00b0C, maintained with ice packs at the groin and neck and a cold-air tunnel around the patient\u2019s body\n\nControl\n\nNo target temperature set\n\nFor both intervention and control group\n\nPropofol as sedative agent\nContinuous EEG monitoring within 2 hours of randomisation\n\nContinued for at least 48 hours or normothermia in the intervention group\n\n\nStandard EEG extracted and intepreted by neurophysiologists\nIf EEG-proven seizure activity seen, propofol administered to achieve burst-suppression pattern for 24 hours\nContinuous core temperature monitoring by oesophageal probe\n\nOutcome\n\nPrimary outcome:\u00a0GOS score of 5 (indicating survival with no or minimal neurological deficit)\n\nNo significant difference: 49% in intervention vs 43% in control (CI 0.75 \u2013 1.99, p=0.43)\n\n\nSecondary outcomes: comparing intervention\u00a0vs. control group\n\nNo significant difference in:\n\nICU mortality: 9% vs 12%, odds\u00a0ratio 0.83 (CI 0.38 \u2013 1.82, p=0.64)\nHospital mortality: 12% vs 15%, odds\u00a0ratio 0.81 (CI 0.40 \u2013 1.64, p=0.55)\nMortality at 90 days post discharge: 13% vs 15%, odds\u00a0ratio 0.86 (CI 0.43 \u2013 1.72, p=0.67)\nTotal seizure duration: Median 75min vs 90min, p=0.26)\nRefractory status epilepticus on day 1: 31% vs 50%, odds ratio 0.68 (CI 0.40 \u2013 1.15, p=0.15)\nSuper-refractory status epilepticus, defined as ongoing or recurrent status epilepticus between 24 and 48 hours after the initiation of anaesthetic treatment: 17% vs 23%, odds ratio 0.64 (CI 0.34 \u2013 1.159, p=0.16)\nLength of stay in ICU: Median 8 days vs 7 days, p=0.44\nLength of stay in hospital: Median 21 days vs 19 days, p=0.89\nIncidents of 1 or more adverse events: 85% vs 77%\n\n\nSignificant difference in progression in EEG-confirmed status epilepticus: 11% vs 22%, odds ratio 0.4 (CI 0.20 \u2013 0.79, p=0.009)\n\n\n\nAuthors\u2019 Conclusions\n\nIn critically ill patients with convulsive status epilepticus receiving mechanical ventilation, the addition of therapeutic hypothermia to standard antiepileptic therapy showed no significant benefit with respect to good functional outcome\n\nStrengths\n\nRCT\nIncidence of primary outcome in control group in line with power calculations\nStandardised initial treatment with anti-epileptic drugs similar in both groups\nStandardised sedation protocol\nSeparation of temperature between intervention and control group achieved\nHypothermia target achieved in 98% of patients randomised to intervention group\n\nWeaknesses\n\nOnly 25% of patients were in status epilepticus as defined at the time of randomisation\nEarly utilisation of hypothermia not standard practice\n\nThe Bottom Line\n\nThis study only looked at patients with status epilepticus requiring mechanical ventilation. Despite the early use of induced hypothermia, the lack of clear functional benefit means that I would continue not to use it in my current practice.\n\nExternal Links\n\n[article]\u00a0Hypothermia for Neuroprotection in Convulsive Status Epilepticus\n[FOAMed] St. Emlyn\u2019s. Hypothermia in status epilepticus\n[FOAMed]\u00a0CC Nerd-The Case of the Uncertain Surrogate CC Nerd-The Case of the Uncertain Surrogate\n\nMetadata\nSummary author:\u00a0@avkwong\nSummary date:\u00a04th January 2017\nPeer-review editor: @stevemathieu75\n\n\n"
}